| Current Price | $30.57 | Mkt Cap | $5.9B |
|---|---|---|---|
| Open | $31.59 | P/E Ratio | 171.74 |
| Prev. Close | $30.57 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $30.15 - $33.49 | Volume | 6,521,378 |
| 52-Wk Range | $2.20 - $53.69 | Avg. Daily Vol. | 5,475,653 |
| Current Price | $30.57 | Mkt Cap | $5.9B |
|---|---|---|---|
| Open | $31.59 | P/E Ratio | 171.74 |
| Prev. Close | $30.57 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $30.15 - $33.49 | Volume | 6,521,378 |
| 52-Wk Range | $2.20 - $53.69 | Avg. Daily Vol. | 5,475,653 |
The best Bull and Bear pitches based on recency and number of recommendations.
The rational is the same as for Illumina. Genome sequencing will take on greater and greater importance in the future.
Read the most recent pitches from players about PACB.
Recs
1russianguy
(97.07)
Submitted: 2/23/2021 1:01:53 PM :
Start Price:
$39.35
NASDAQ:PACB Score:
-20.02
Three Stocks With 1,000% ROI Potential, as of Feb. 21'. https://www.youtube.com/watch?v=URCkYR_0Ws8
Recs
wrciii
(89.28)
Submitted: 2/23/2021 12:43:56 AM :
Start Price:
$41.46
NASDAQ:PACB Score:
-25.15
ARKG
Recs
worde100
(< 20)
Submitted: 1/13/2021 10:02:46 PM :
Start Price:
$35.34
NASDAQ:PACB Score:
-13.42
Long-read sequencing technology is better at identifying structural variants in genomes than short-read sequencing. PacBio's has a lot of growth to realize just from a marketing and sales perspective. The CEO is pushing to get PacBio's systems out to more labs as well as aggressively lower prices. PacBio will overtake Illumina as the dominate sequencing machine provider.
Find the members with the highest scoring picks in PACB.
IdahoAve (83.50) Score: +1,626.61
The Score Leader is the player with the highest score across all their picks in PACB.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| IdahoAve | 83.50 | 11/28/2012 |
|
5Y | $1.61 | +1,798.76% | +172.15% | +1,626.61 | 0 Comment | |
| codyjr002 | 86.11 | 8/22/2012 |
|
5Y | $1.81 | +1,588.95% | +169.41% | +1,419.54 | 0 Comment | |
| AFMS | 43.19 | 8/31/2012 |
|
5Y | $1.92 | +1,493.85% | +168.84% | +1,325.00 | 0 Comment | |
| snscblue1 | 65.64 | 9/13/2012 |
|
5Y | $2.00 | +1,428.50% | +159.35% | +1,269.15 | 0 Comment | |
|
franniemarie | 78.35 |
|
|
5Y | $1.98 | +1,443.94% | +184.36% | +1,259.58 | 0 Comment |
| mattyabe | 34.98 | 6/25/2012 |
|
5Y | $2.00 | +1,428.50% | +188.04% | +1,240.46 | 1 Comment | |
| fiveforthemoney | 97.87 | 7/25/2012 |
|
NS | $2.03 | +1,405.91% | +183.20% | +1,222.71 | 0 Comment | |
| TexasChris | 74.14 | 3/18/2013 |
|
5Y | $2.22 | +1,277.03% | +146.44% | +1,130.58 | 0 Comment | |
| AndreyGR | < 20 | 5/22/2012 |
|
5Y | $2.24 | +1,264.73% | +186.57% | +1,078.17 | 0 Comment | |
| vivsiv | < 20 | 4/15/2013 |
|
3Y | $2.34 | +1,206.41% | +140.73% | +1,065.68 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
